Open AccessIs there any priority between the alpha blockers on voiding functions after transrectal ultrasound guided prostate biopsy?
Author(s) -
Ozan Efesoy,
Barış Saylam,
Mesut Tek,
Murat Bozlu,
Erdem Akbay
Publication year - 2021
Publication title -
turkish journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.347
H-Index - 8
eISSN - 2149-3057
pISSN - 2149-3235
DOI - 10.5152/tud.2021.20509
Subject(s) - prostate , ultrasound , medicine , prostate biopsy , alpha (finance) , urology , radiology , surgery , construct validity , patient satisfaction , cancer
Transrectal ultrasound-guided prostate biopsy is the gold standard in the diagnosis of prostate cancer. Major and minor complications may develop at varying rates after prostate biopsies, one of which is voiding impairment. This study aimed to evaluate whether all alpha1-blockers were effective in preventing voiding impairment after a transrectal ultrasound-guided prostate biopsy and if so, was one superior to the others.